COVID-19 pandemic is a pandemic of antimicrobial therapy.
Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia
; 23(1):5-15, 2021.
Article
in Russian
| EMBASE | ID: covidwho-2304450
ABSTRACT
The article presents a critical analysis of antibiotic usage tactics in the treatment of patients with COVID-19 existing in Russian and foreign healthcare, and discusses the possible causes of unjustified antibiotic aggression in this category of patients. The potential negative consequences of the widespread use of antibiotics in patients carrying a new coronavirus infection are analyzed life-threatening cardiotoxicity in patients with the simultaneous administration of such a "popular" candidate etiologic therapy as a combination of azithromycin and hydroxychloroquine, the potential development of other serious adverse drug reactions (in particular, the development of an antibiotic-associated pseudomembranous colitis, etc.), the expected dramatic increase in the secondary drug resistance of potentially pathogenic microorganisms to widely and often prescribed antibiotics.Copyright © 2021, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy. All rights reserved.
Antibacterial therapy; Antimicrobial resistance; covid-19; Pneumonia; adverse drug reaction; antibiotic resistance; antimicrobial therapy; article; cardiotoxicity; coronavirus disease 2019/di [Diagnosis]; coronavirus disease 2019/dt [Drug Therapy]; coronavirus disease 2019/th [Therapy]; drug use; health care system; human; life threat; pandemic/di [Diagnosis]; pandemic/th [Therapy]; Russian Federation; azithromycin/cb [Drug Combination]; azithromycin/dt [Drug Therapy]; hydroxychloroquine/cb [Drug Combination]; hydroxychloroquine/dt [Drug Therapy]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Russian
Journal:
Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS